Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT8 Antikörper

Der Maus Monoklonal Anti-KRT8-Antikörper wurde für WB, IF, FACS und IHC (p) validiert. Er ist geeignet, KRT8 in Proben von Human, Ratte und Zebrafisch (Danio rerio) zu detektieren.
Produktnummer ABIN3024660

Kurzübersicht für KRT8 Antikörper (ABIN3024660)

Target

Alle KRT8 Antikörper anzeigen
KRT8 (Keratin 8 (KRT8))

Reaktivität

  • 314
  • 88
  • 78
  • 67
  • 65
  • 63
  • 62
  • 16
  • 14
  • 9
  • 8
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Ratte, Zebrafisch (Danio rerio)

Wirt

  • 168
  • 163
  • 3
Maus

Klonalität

  • 184
  • 147
  • 1
Monoklonal

Konjugat

  • 172
  • 27
  • 17
  • 12
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT8 Antikörper ist unkonjugiert

Applikation

  • 239
  • 176
  • 123
  • 88
  • 71
  • 49
  • 48
  • 41
  • 41
  • 40
  • 37
  • 29
  • 22
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

H1
  • Aufreinigung

    Protein G affinity chromatography

    Immunogen

    A cytoskeleton preparation containing Cytokeratin 8 was used as the immunogen for this antibody.

    Isotyp

    IgG1
  • Applikationshinweise

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Citrate Buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Western blot: 1-2 μg/mL,FACS: 0.5-1 μg/million cells,IF: 1-2 μg/mL,IHC (FFPE): 0.5-1.0 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Konservierungsmittel

    Azide free

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the Cytokeratin 8 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    KRT8 (Keratin 8 (KRT8))

    Andere Bezeichnung

    Cytokeratin 8

    Hintergrund

    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). Cytokeratin 8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibody that recognizes only cytokeratin 8 and 18. Cytokeratin 8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. antibody to Cytokeratin 8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against Cytokeratin 8, 18 and 19). Reportedly, Cytokeratin 8 antibody is useful for the differentiation of lobular (""ring-like, perinuclear"") from ductal (""peripheral-predominant"") carcinoma of the breast.

    Gen-ID

    3856
Sie sind hier:
Chat with us!